Please login to the form below

Not currently logged in
Email:
Password:

Eucrisa

This page shows the latest Eucrisa news and features for those working in and with pharma, biotech and healthcare.

Daily brief: Novartis spends big on ezcema,

Daily brief: Novartis spends big on ezcema,

There is plenty of competition in the field, with Pfizer’s Eucrisa and Regeneron and Sanofi’s Dupixent already on the market.

Latest news

  • Dermira craters as acne drug fails late-stage test Dermira craters as acne drug fails late-stage test

    s IL-4 and IL-13-targeting drug Dupixent (dupilumab), Pfizer’s new topical treatment Eucrisa (crisaborole) and potentially other drugs such as GlaxoSmithKline’s asthma drug Nucala (mepolizumab), which is

  • Roche out-licenses lebrikizumab rights to Dermira Roche out-licenses lebrikizumab rights to Dermira

    Meanwhile, Pfizer is starting to make headway with its new topical treatment Eucrisa (crisaborole), which pulled in $17m in the first half of the year after its approval last December.

  • Regeneron bags US approval for eczema drug Dupixent Regeneron bags US approval for eczema drug Dupixent

    Dupixent's approval comes just a few weeks after Pfizer won a green light from the regulator for Eucrisa (crisaborole) for patients with milder forms of atopic dermatitis - which the company

  • Novartis adds oral eczema drug with Ziarco acquisition Novartis adds oral eczema drug with Ziarco acquisition

    The deal comes hard on the heels of Pfizer gaining FDA approval of its Eucrisa (crisaborole) topical treatment for eczema - also known as atopic dermatitis - which is predicted to become a

  • FDA green light for Pfizer's eczema drug FDA green light for Pfizer's eczema drug

    FDA green light for Pfizer's eczema drug. Blockbuster-hopeful Eucrisa expected to launch early next year at $580 per 60mg tube. ... The pharma leviathan has priced Eucrisa at $580 for a 60g tube, before any discounts or rebates, and expects to launch it

More from news
Approximately 2 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Lucid Group Communications Limited

We are industry-leading thinkers when it comes to education. We use the latest academic thinking on the psychology of behaviour...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics